Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Market Perspective (2018-2033)
2.2 Celiac Disease Growth Trends by Region
2.2.1 Global Celiac Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Celiac Disease Historic Market Size by Region (2018-2023)
2.2.3 Celiac Disease Forecasted Market Size by Region (2024-2033)
2.3 Celiac Disease Market Dynamics
2.3.1 Celiac Disease Industry Trends
2.3.2 Celiac Disease Market Drivers
2.3.3 Celiac Disease Market Challenges
2.3.4 Celiac Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Players by Revenue
3.1.1 Global Top Celiac Disease Players by Revenue (2018-2023)
3.1.2 Global Celiac Disease Revenue Market Share by Players (2018-2023)
3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Revenue
3.4 Global Celiac Disease Market Concentration Ratio
3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2022
3.5 Celiac Disease Key Players Head office and Area Served
3.6 Key Players Celiac Disease Product Solution and Service
3.7 Date of Enter into Celiac Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Breakdown Data by Type
4.1 Global Celiac Disease Historic Market Size by Type (2018-2023)
4.2 Global Celiac Disease Forecasted Market Size by Type (2024-2033)
5 Celiac Disease Breakdown Data by Application
5.1 Global Celiac Disease Historic Market Size by Application (2018-2023)
5.2 Global Celiac Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Celiac Disease Market Size (2018-2033)
6.2 North America Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Celiac Disease Market Size by Country (2018-2023)
6.4 North America Celiac Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Celiac Disease Market Size (2018-2033)
7.2 Europe Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Celiac Disease Market Size by Country (2018-2023)
7.4 Europe Celiac Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Market Size (2018-2033)
8.2 Asia-Pacific Celiac Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Celiac Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Celiac Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Celiac Disease Market Size (2018-2033)
9.2 Latin America Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Celiac Disease Market Size by Country (2018-2023)
9.4 Latin America Celiac Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Market Size (2018-2033)
10.2 Middle East & Africa Celiac Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Celiac Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Celiac Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Celiac Disease Introduction
11.1.4 Roche Revenue in Celiac Disease Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Celiac Disease Introduction
11.2.4 Merck Revenue in Celiac Disease Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Celiac Disease Introduction
11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 BiolineRx
11.4.1 BiolineRx Company Detail
11.4.2 BiolineRx Business Overview
11.4.3 BiolineRx Celiac Disease Introduction
11.4.4 BiolineRx Revenue in Celiac Disease Business (2018-2023)
11.4.5 BiolineRx Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Celiac Disease Introduction
11.5.4 Pfizer Revenue in Celiac Disease Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Innovate Biopharmaceuticals
11.6.1 Innovate Biopharmaceuticals Company Detail
11.6.2 Innovate Biopharmaceuticals Business Overview
11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2018-2023)
11.6.5 Innovate Biopharmaceuticals Recent Development
11.7 ImmusanT
11.7.1 ImmusanT Company Detail
11.7.2 ImmusanT Business Overview
11.7.3 ImmusanT Celiac Disease Introduction
11.7.4 ImmusanT Revenue in Celiac Disease Business (2018-2023)
11.7.5 ImmusanT Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Celiac Disease Introduction
11.8.4 Novartis Revenue in Celiac Disease Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Celiac Disease Introduction
11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2018-2023)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Immunomedics
11.10.1 Immunomedics Company Detail
11.10.2 Immunomedics Business Overview
11.10.3 Immunomedics Celiac Disease Introduction
11.10.4 Immunomedics Revenue in Celiac Disease Business (2018-2023)
11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Distension
Table 3. Key Players of Diarrhea
Table 4. Key Players of Anorexia
Table 5. Key Players of Others
Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Celiac Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Celiac Disease Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Celiac Disease Market Share by Region (2018-2023)
Table 10. Global Celiac Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Celiac Disease Market Share by Region (2024-2033)
Table 12. Celiac Disease Market Trends
Table 13. Celiac Disease Market Drivers
Table 14. Celiac Disease Market Challenges
Table 15. Celiac Disease Market Restraints
Table 16. Global Celiac Disease Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Celiac Disease Market Share by Players (2018-2023)
Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2022)
Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Celiac Disease Product Solution and Service
Table 23. Date of Enter into Celiac Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Celiac Disease Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Celiac Disease Revenue Market Share by Type (2018-2023)
Table 27. Global Celiac Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Celiac Disease Revenue Market Share by Type (2024-2033)
Table 29. Global Celiac Disease Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Celiac Disease Revenue Market Share by Application (2018-2023)
Table 31. Global Celiac Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Celiac Disease Revenue Market Share by Application (2024-2033)
Table 33. North America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Celiac Disease Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Celiac Disease Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Celiac Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Celiac Disease Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Celiac Disease Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Celiac Disease Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Celiac Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Celiac Disease Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Celiac Disease Market Size by Country (2024-2033) & (US$ Million)
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Celiac Disease Product
Table 51. Roche Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Celiac Disease Product
Table 56. Merck Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Johnson & Johnson Company Detail
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Celiac Disease Product
Table 61. Johnson & Johnson Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. BiolineRx Company Detail
Table 64. BiolineRx Business Overview
Table 65. BiolineRx Celiac Disease Product
Table 66. BiolineRx Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 67. BiolineRx Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Celiac Disease Product
Table 71. Pfizer Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Innovate Biopharmaceuticals Company Detail
Table 74. Innovate Biopharmaceuticals Business Overview
Table 75. Innovate Biopharmaceuticals Celiac Disease Product
Table 76. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 77. Innovate Biopharmaceuticals Recent Development
Table 78. ImmusanT Company Detail
Table 79. ImmusanT Business Overview
Table 80. ImmusanT Celiac Disease Product
Table 81. ImmusanT Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 82. ImmusanT Recent Development
Table 83. Novartis Company Detail
Table 84. Novartis Business Overview
Table 85. Novartis Celiac Disease Product
Table 86. Novartis Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Bristol-Myers Squibb Company Detail
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Celiac Disease Product
Table 91. Bristol-Myers Squibb Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Immunomedics Company Detail
Table 94. Immunomedics Business Overview
Table 95. Immunomedics Celiac Disease Product
Table 96. Immunomedics Revenue in Celiac Disease Business (2018-2023) & (US$ Million)
Table 97. Immunomedics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Celiac Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Celiac Disease Market Share by Type: 2022 VS 2033
Figure 3. Distension Features
Figure 4. Diarrhea Features
Figure 5. Anorexia Features
Figure 6. Others Features
Figure 7. Global Celiac Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Celiac Disease Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Celiac Disease Report Years Considered
Figure 12. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Celiac Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Celiac Disease Market Share by Region: 2022 VS 2033
Figure 15. Global Celiac Disease Market Share by Players in 2022
Figure 16. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2022
Figure 18. North America Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Celiac Disease Market Share by Country (2018-2033)
Figure 20. United States Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Celiac Disease Market Share by Country (2018-2033)
Figure 24. Germany Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Celiac Disease Market Share by Region (2018-2033)
Figure 32. China Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Celiac Disease Market Share by Country (2018-2033)
Figure 40. Mexico Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Celiac Disease Market Share by Country (2018-2033)
Figure 44. Turkey Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Celiac Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 49. BiolineRx Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 51. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 52. ImmusanT Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 55. Immunomedics Revenue Growth Rate in Celiac Disease Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed